| |
AboBoNT-A LS Mean (95% CI)
|
OnaBoNT-A LS Mean (95% CI)
|
Differenceb (95% CI)
|
|---|
|
Unadjusted Model
|
310.31 (294.83, 325.78)
|
355.87 (331.61, 380.13)
|
−45.57 (−74.35, − 16.79)
|
|
Adjusted Modelc
|
314.07 (299.1, 329.03)
|
346.63 (322.85, 370.42)
|
−32.57 (− 61.04, − 4.09)
|
- aCost was calculated based on retail drug cost in euros
- bDifference was calculated as: mean of aboBoNT-A minus mean of onaBoNT-A
- cModel adjusted for sex, prior treatment with botulinum neurotoxin type A and electromyography (EMG) at baseline
- aboBoNT-A abobotulinumtoxinA; onaBoNT-A onabotulinumtoxinA; LS Least-Square; CI Confidence Interval
